Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 10,016 shares at $23.00 ($220K) on 2017-01-05, disclosed to the SEC on 2017-01-09.
Scheduled sale ($220k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.00 | 2,216 | $51K | 23.2% |
| 2 | $23.02 | 6,800 | $157K | 71.2% |
| 3 | $1.65 | 500 | $825 | 0.4% |
| 4 | $23.00 | 500 | $12K | 5.2% |
| Total | $21.95 avg | 10,016 | $220K | 100% |
| Filing → |
| ATHA | SELL | 2025-07-02 | $7K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $14K | — | Filing → |
| ATHA | SELL | 2024-09-05 | $3K | — | Filing → |